共 166 条
[1]
Okwundu CI(2012)Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals Cochrane Database Syst Rev 7 CD007189-348
[2]
Uthman OA(2014)HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention J Acquir Immune Defic Syndr 66 340-40
[3]
Okoromah CA(2016)Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review BMJ Glob Heal 1 e000125-61
[4]
Donnell D(2016)Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. Weiser SD, editor PLoS Med 13 e1002183-1607
[5]
Baeten JM(2017)Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis Lancet HIV 4 e31-318
[6]
Bumpus NN(2019)Pre-exposure prophylaxis use and medication adherence among men who have sex with men J Assoc Nurses AIDS Care 30 e38-1173
[7]
Brantley J(2017)HIV drug resistance—an emerging threat to epidemic control N Engl J Med. 377 1605-6
[8]
Bangsberg DR(2019)A Comparison of plasma efavirenz and tenofovir, dried blood spot tenofovir-diphosphate, and self-reported adherence to predict virologic suppression among South African women J Acquir Immune Defic Syndr 81 311-256
[9]
Haberer JE(2016)Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study AIDS Res Ther 13 16-169
[10]
Heestermans T(2018)Utility of different adherence measures for PrEP: patterns and incremental value AIDS Behav. 22 1165-313